Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-04-05
2005-04-05
Shameem, Golam M M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S364100, C544S106000, C544S140000
Reexamination Certificate
active
06875789
ABSTRACT:
Described herein are compounds that are useful as protein kinase inhibitors having the formula:where B, R1, n, R3, Q, and R4are described in the specification. The compounds are useful for treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.
REFERENCES:
patent: 5922741 (1999-07-01), Davis et al.
patent: 5932576 (1999-08-01), Antantanarayan et al.
patent: WO 9852941 (1998-11-01), None
patent: WO 0156993 (2001-08-01), None
patent: WO 0157022 (2001-08-01), None
patent: WO 0222610 (2002-03-01), None
Ambinter: “Screening Collection (catalog)”; Abstract, Accession No. 2001:326873 Chemcats, CAS Registry No. 321553-20-2; publication date Aug. 23, 1999.
Hale Michael Robin
Janetka James Walter
Maltais Francois
Tang Qing
Choate Hall & Stewart
Robidoux Andrea L. C.
Shameem Golam M M
Vertex Pharmaceuticals Incorporated
LandOfFree
Pyrazole-derived kinase inhibitors and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazole-derived kinase inhibitors and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazole-derived kinase inhibitors and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3424636